ArticleMethods in molecular biology (Clifton, N.J.)2026
Predictive Model for Single-Site Mutations That Change Intrinsically Disordered Protein Binding Energetics.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intrinsically disordered proteins (IDPs) are characterized by structural mobility and lack of stable tertiary structure. These are important for IDP functions and interactions with other protein partners. IDP binding modes are distinctly divergent from globular protein-protein interactions. Comprehensive studies on effects of mutations in this structurally distinct protein class of IDPs are limited, impeding the development of accurate prediction methods for mutational effects in IDPs. Understanding how mutations affect IDP binding affinity is also crucial to peptide drug design, therapeutics engineering, and research on IDP diseases. Previous deep mutational scanning study of intrinsically disordered domain of control of cell death protein A (CcdA) shed light on residue-specific contribution to cognate partner binding energetics and outlined methodology for building IDP-compatible prediction models of binding affinity. The current chapter summarizes our previously described methodology [1] (see Notes 1, 4-7) for development of a linear regression-based predictive model, Intrinsically disordered Protein Affinity prediction (IPApred). Our method incorporates structural information at the residue level as well as experimentally derived mutational penalties while leveraging the distinct physicochemical properties of different amino acids to predict how single-site substitutions affect partner binding in IDPs. We describe methods for data generation and collection, and the steps of selecting features, training a simple mathematical model, outlining a protocol for using IPApred, and finally discussing validation and evaluation of the model. The chapter also highlights current limitations of the model and challenges faced in modeling IDP energetics and discusses possible strategies of addressing them. Despite drawbacks, IPApred provides a useful framework for predicting mutational effects in disordered proteins and for improved understanding of related biological processes and disease mechanisms.
Indexed as
Identifiers
41174305What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.